ACLARION, INC. Increase (Decrease) in Other Operating Assets and Liabilities, Net
ACLARION, INC. (ACON) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $889.08 thousand for the 9-month period ending 2022-09-30, per its 10-K/A filed 2023-06-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2023-06-12
- ACLARION, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2022-09-30 was -$158.46K.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month |
|---|---|---|---|
| 2022-09-30 | -$158.46K derived: 10-K/A 9 month − 10-K/A 6 month · filed 2023-06-12 | $889.08K 10-K/A · filed 2023-06-12 | |
| 2022-06-30 | $1.05M 10-K/A · filed 2023-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |